Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats

Arch Med Res. 2002 May-Jun;33(3):305-7. doi: 10.1016/s0188-4409(01)00379-4.

Abstract

Background: Even moderate increases in levels of homocysteine cause cardiovascular degeneration. Various genetic and nutritional factors affect plasma homocysteine concentrations, and hyperhomocysteinemia damages vascular endothelial cells; hence their functions are disrupted. In diabetes mellitus, homocysteine metabolism is altered and as a result, more severe diabetic complications are expected when hyperhomocysteinemia occurs.

Methods: In the present study we experimentally induced diabetes in rats and examined effects of low or high dose of insulin administration on homocysteine metabolism.

Results: We determined that homocysteine levels were reduced in STZ-induced diabetic rats. This reduction was normalized by insulin in a dose-dependent manner. On the other hand, increased levels of lipid parameters (cholesterol, triglycerides, HDL) were reduced by insulin.

Conclusions: Hcy level in experimentally induced insulin-dependent diabetes mellitus is decreased and injection of insulin normalizes Hcy levels in a dose-dependent manner. We speculate that insulin increases activities of enzymes of transsulfuration and remethylation reactions and hence speeds up conversion of Hcy to methionine and cysteine.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / blood*
  • Dose-Response Relationship, Drug
  • Homocysteine / blood*
  • Insulin / administration & dosage
  • Insulin / pharmacology*
  • Rats
  • Streptozocin

Substances

  • Insulin
  • Homocysteine
  • Streptozocin